Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Christopher Teng, cataract and glaucoma expert, named new chair of Department of Ophthalmology & Visual Sciences – UMass Chan Medical School
Christopher Teng, cataract and glaucoma expert, named new chair of Department of Ophthalmology & Visual Sciences UMass Chan Medical School Source: Author: | Date: 2024-09-26 07:00:00 Source: Author: | Date: 2024-09-26 07:00:00
Embracing generative AI in ophthalmology – British Journal of Ophthalmology
Embracing generative AI in ophthalmology British Journal of Ophthalmology Source: Author: | Date: 2024-09-20 12:20:00 Source: Author: | Date: 2024-09-20 12:20:00
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye – Nature
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye Nature Source: Author: | Date: 2024-09-19 07:00:00 Source: Author: | Date: 2024-09-19 07:00:00
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation – CU Anschutz newsroom
CU Ophthalmology Researcher Awarded Funding to Further Study Uveitis and Ocular Inflammation CU Anschutz newsroom Source: Author: | Date: 2024-09-09 07:00:00 Source: Author: | Date: 2024-09-09 07:00:00
Topcon and Orbis Partner to Expand DR Screening in Rwanda
Topcon Healthcare, in collaboration with Orbis International and the Rwanda International Institute of Ophthalmology (RIIO), has embarked on an initiative to enhance diabetic retinopathy screening in Rwanda. Donation of Robotic Retinal Cameras To facilitate this effort, Topcon has generously donated…
Trial Results for Susvimo Show Sustained Efficacy in DME and DR
Genentech and Roche released compelling 2-year data from the phase 3 Pagoda and Pavilion studies evaluating Susvimo (ranibizumab injection) 100 mg/mL, marking a significant development in the treatment landscape for diabetic macular edema (DME) and diabetic retinopathy (DR). Reintroduction of…
Okyo Pharma’s Phase 2 Trial for Neuropathic Corneal Pain
Okyo Pharma announced its plan to initiate a phase 2 clinical trial for OK-101 in the treatment of neuropathic corneal pain (NCP), scheduled to begin in the third quarter of 2024. This one-year study follows promising results from preclinical animal…
Opthea Forms Medical Advisory Board with Global Retina Experts
Opthea announced the formation of its Medical Advisory Board (MAB), comprised of ten distinguished thought leaders in the field of retina from across the globe. The board includes experts from the United States, Argentina, Australia, China, France, Germany, and Israel,…
NexThera Submits IND Application for NT-101 for Wet AMD
NexThera has officially submitted a Phase 1/2a Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for NT-101, an innovative non-invasive eye drop treatment targeting wet age-related macular degeneration (wet AMD). Proprietary Delivery Platform: Advancing Treatment…
Funding Boost for PulseMedica’s Eye Floater Technology
PulseMedica has successfully raised a total of $12 million in their recent pre-Series A financing round, marking a significant milestone in their pursuit of innovative eye floater diagnostic and treatment technologies. Accelerating Clinical Validation and Expansion Efforts This funding round…